Bruker

Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates

Retrieved on: 
Monday, April 8, 2024
Research, Technology, Semiconductor, Genetics, Health Technology, Nanotechnology, Biotechnology, Hardware, Health, Science, CNRS, CPMAS, 2000s, HCN, Membrane, Corporation, DNP, NMR, Bruker, Hertz, Protein, Multimedia, MAS, BRKR, WB, Medical imaging

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membrane proteins and in protein aggregates.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membrane proteins and in protein aggregates.
  • Featuring a 160 kHz Magic Angle Spinning (MAS) system, it takes high-resolution MAS and proton detection on solid biological samples to the next level, enabling new scientific discoveries.
  • The dramatically enhanced 1H-NMR resolution and enhanced T2' times make 160 kHz MAS suitable for the study of large proteins, membrane proteins and protein aggregates.
  • In addition, a 160 kHz MAS probe is now installed on the 1.0 GHz NMR at CNRS Lyon, where it expands the scientific capabilities of biological solid-state research.

Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies

Retrieved on: 
Monday, April 8, 2024
Biotechnology, Technology, Professional Services, Health, Pharmaceutical, Semiconductor, Research, Data Analytics, Software, Science, Hardware, Quality control, Evo, Corporation, NMR, Active ingredient, Bruker, AI, Ascend, PAT, API, Safety, Magnet, Hertz, Machine learning, Multimedia, Fourier, BRKR, Medical imaging

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies (PAT).

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies (PAT).
  • The new Ascend Evo 600 magnet is easier to site, has reduced installation and operational costs, and has lower Helium consumption compared to previous 600 MHz magnets.
  • In addition, Bruker expands the applications of its Fourier 80 platform, a benchtop 80 MHz Fourier Transform NMR with a high-performance permanent magnet that requires no cryogens or power.
  • Here, the Fourier 80 system gathers reaction data for AI machine learning to formulate the rules and actions to guide process optimization.

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

Retrieved on: 
Monday, March 18, 2024
Medical Devices, Health, Hospitals, Surgery, General Health, Biotechnology, Inclusion, NuVasive, Bruker, Equity, Therapy, CHRO, Spine, Multimedia, Business operations, Elective surgery, Management

(NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer.

Key Points: 
  • (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240318931186/en/
    Lucas Vitale, appointed Chief People and Business Operations Officer at Orthofix (Photo: Business Wire)
    Vitale most recently served as the Chief Human Resources Officer (CHRO) at ReNAgade Therapeutics, a venture backed pharmaceutical company, and prior to that, he served as the CHRO at Berkeley Lights/PhenomeX, a life sciences tools and services company acquired by Bruker.
  • “We are pleased to welcome Lucas to our executive leadership team,” said Massimo Calafiore, President and Chief Executive Officer of Orthofix.
  • “In this pivotal role, he will lead the company’s ongoing integration and business transformation strategies as we continue to strengthen our infrastructure to support future growth.”
    “I am excited by the continued opportunities to bring Orthofix and SeaSpine together,” said Lucas Vitale, Chief People and Business Operations Officer.

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

Retrieved on: 
Monday, March 11, 2024
Software, Research, Hardware, Pharmaceutical, Oncology, Technology, Medical Devices, Infectious Diseases, Genetics, Health Technology, Science, Biotechnology, Health, QC, GPU, Utrecht University, Pharmacy, IRT, Drug discovery, Radboud University Nijmegen, Cell biology, Biomarker, Molecular genetics, Bruker, University, Ultra, University of Michigan, Proteomics, Peptide, Infection, Pulse, Neoplasm, Glycomics, Lunenfeld-Tanenbaum Research Institute, TIMS, Multimedia, Medical director, BRKR, Pathology, Medical device

At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows.

Key Points: 
  • At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows.
  • The rapid advances in deep, at-scale proteomics, glycomics and peptidomics research solutions complement other performance-leading life-science tools for the post-genomic era by Bruker.
  • Bruker enhances its timsTOF HT and timsTOF Ultra systems with the new software Novor v2.0 for de novo immunopeptidomic profiling.
  • Our software suite supports the analysis of PASEF data, and we are delighted that Bruker now offers it with timsTOF instruments.

IR Spectroscopy Market worth $1.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, April 3, 2024
LWIR, Environmental monitoring, Statistics, PerkinElmer, MCT, Quality control, Shortwave radio, Infrared, Indium gallium arsenide, Monitoring, Indium arsenide, Near, FT, Food, Cooling, Bruker, MWIR, Shimadzu, Agilent Technologies, Countertop, Miniaturization, Mercury cadmium telluride, Security, SWIR, Microscopy

The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.

Key Points: 
  • The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.
  • Back Office & Other Services segment accounted for the largest share of ~52% of the IR spectroscopy market in 2029.
  • Europe is expected to hold the second largest share of the IR spectroscopy market during the forecast period.
  • Europe held the second largest share of ~31% in the IR spectroscopy industry in 2029.

IR Spectroscopy Market worth $1.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, April 3, 2024
LWIR, Environmental monitoring, Statistics, PerkinElmer, MCT, Quality control, Shortwave radio, Infrared, Indium gallium arsenide, Monitoring, Indium arsenide, Near, FT, Food, Cooling, Bruker, MWIR, Shimadzu, Agilent Technologies, Countertop, Miniaturization, Mercury cadmium telluride, Security, SWIR, Microscopy

The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.

Key Points: 
  • The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.
  • Back Office & Other Services segment accounted for the largest share of ~52% of the IR spectroscopy market in 2029.
  • Europe is expected to hold the second largest share of the IR spectroscopy market during the forecast period.
  • Europe held the second largest share of ~31% in the IR spectroscopy industry in 2029.

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results

Retrieved on: 
Thursday, March 28, 2024
Research, Acceleration, Environment, International, Telephone, Security (finance), Table, Bruker, Cost, Investment, GAAP, Sensitivity and specificity, Pheno, FDA, Food

TUCSON, Ariz., March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • TUCSON, Ariz., March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023.
  • Net sales for the quarter were $3.0 million, compared to $3.0 million for the same quarter of the prior year.
  • Management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to review 2023 fourth quarter and full year results.
  • To listen to the 2023 fourth quarter and full year results, call by phone, +1.877.883.0383 and enter Elite Entry Number: 7172610. International participants may dial +1.412.902.6506.

Transmission Electron Microscope Market Projected to Reach $3.92 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Thursday, March 28, 2024
Dark, Growth, Transmission electron cryomicroscopy, Thermo Fisher Scientific, Critical Role, Science, Intelligence, Nanoparticle, Research, Electron, Electronics, Nanotechnology, TEM, AI, Dislocation, Bruker, Biology, NanoWorld, Hitachi, Transmission electron microscopy, Architecture, Investment, Semiconductor, Miniaturization, Aberration, Interference microscopy, Table, Carl Zeiss AG, Microscope

Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.

Key Points: 
  • Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.
  • The key players in the Transmission Electron Microscope Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, AMETEK, Inc, Bruker Corporation, Hitachi Ltd., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Transmission Electron Microscope Market.
  • "Dive into the Transmission Electron Microscope Market Landscape: Explore 183 Pages of Insights, 574 Tables, and 26 Figures"

Transmission Electron Microscope Market Projected to Reach $3.92 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Thursday, March 28, 2024
Dark, Growth, Transmission electron cryomicroscopy, Thermo Fisher Scientific, Critical Role, Science, Intelligence, Nanoparticle, Research, Electron, Electronics, Nanotechnology, TEM, AI, Dislocation, Bruker, Biology, NanoWorld, Hitachi, Transmission electron microscopy, Architecture, Investment, Semiconductor, Miniaturization, Aberration, Interference microscopy, Table, Carl Zeiss AG, Microscope

Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.

Key Points: 
  • Transmission electron microscopy (TEM) is a pivotal analytical tool across various scientific disciplines, including nanotechnology, materials science, and biology.
  • The key players in the Transmission Electron Microscope Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, AMETEK, Inc, Bruker Corporation, Hitachi Ltd., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Transmission Electron Microscope Market.
  • "Dive into the Transmission Electron Microscope Market Landscape: Explore 183 Pages of Insights, 574 Tables, and 26 Figures"

Green Dot Appoints Michael Meston as Chief Human Resources Officer

Retrieved on: 
Monday, February 26, 2024
Software, Internet, Payments, Finance, Banking, Professional Services, Technology, Fintech, Head, Dexcom, Intel, Bruker, Growth, Western Digital, Credibility, As a service, Workforce, GDOT, Green Dot Corporation, Research, Management

Green Dot Corporation (NYSE: GDOT), a leading digital bank and fintech powering consumers and businesses with seamless banking and payment solutions, today announced the appointment of Michael Meston as Chief Human Resources Officer.

Key Points: 
  • Green Dot Corporation (NYSE: GDOT), a leading digital bank and fintech powering consumers and businesses with seamless banking and payment solutions, today announced the appointment of Michael Meston as Chief Human Resources Officer.
  • “Michael is a proven human resources leader with the right experience in organizational change and talent development to help lead Green Dot as we build a workforce committed to seamlessly connecting more people and businesses to their money,” said George Gresham, Chief Executive Officer, Green Dot Corporation.
  • Prior to Bruker Corporation, Meston held senior human resources roles at Dexcom, Western Digital and Intel across the United States and Asia.
  • “Green Dot is enabling a generational shift in how consumers and businesses are accessing and utilizing financial services, and I am excited to contribute to that vision,” said Meston.